Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
Clinical trial NCT03918252 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03918252
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-02
- Primary completion
- 2027-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.